Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 1,075 · FY2023 1,127 · FY2024 800 — 3-yr total 3,001
Georgian pharmacy/pharma-distribution company under the Vitamini brand.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 15.5% | 10.9% | 8.2% | 13.8% | 8.7% | 13.0% | 9.1% |
| EBITDA Margin | 7.5% | 5.2% | 1.5% | 6.0% | 3.0% | 5.8% | 2.8% |
| EBITDAR | 1,755 | 2,547 | 738 | 4,304 | 2,788 | 6,408 | 3,341 |
| EBITDAR Margin | 7.5% | 6.9% | 1.5% | 6.0% | 3.0% | 5.8% | 2.8% |
| EBIT Margin | 7.3% | 5.1% | 1.4% | 6.0% | 2.9% | 5.7% | 2.7% |
| Net Profit Margin | 7.5% | 3.6% | -0.6% | 6.1% | 3.1% | 5.4% | 2.7% |
| Operating Expense % of Sales | 8.0% | 5.7% | 6.7% | 7.8% | 5.7% | 7.3% | 6.3% |
| Returns | |||||||
| Return on Assets (ROA) | 32.0% | 14.5% | -4.3% | 40.7% | 30.5% | 38.9% | 19.5% |
| Return on Equity (ROE) | 123.4% | 51.5% | -14.5% | 69.8% | 35.8% | 46.7% | 20.9% |
| ROIC [EBIT / Invested Capital] | 40.3% | 23.4% | 16.3% | 53.4% | 43.0% | 58.9% | 23.0% |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 62.7% | 63.6% | 32.1% | 23.3% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 2.42x | 2.26x | 1.07x | 0.40x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 1.96x | 3.01x | 3.18x | 0.57x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 25.9% | 28.1% | 29.9% | 58.2% | 85.1% | 83.4% | 93.1% |
| Net Debt | 2,840 | 5,451 | 1,885 | 1,798 | -1,615 | -2,099 | -1,571 |
| Cash & Equivalents | 599 | 360 | 460 | 671 | 1,615 | 2,104 | 1,571 |
| Total Debt | 3,439 | 5,811 | 2,344 | 2,469 | N/A | 5 | N/A |
| Liquidity & working capital | |||||||
| Current Ratio | 7.66x | 1.26x | 1.34x | 2.28x | 6.27x | 5.62x | 13.52x |
| Quick Ratio | 7.66x | 1.15x | 0.97x | 1.89x | 4.50x | 4.92x | 10.71x |
| Cash Ratio | 0.96x | 0.05x | 0.09x | 0.15x | 1.16x | 0.82x | 1.36x |
| Total Current Assets | 4,764 | 8,256 | 6,862 | 10,091 | 8,718 | 14,354 | 15,570 |
| Total Current Liabilities | 622 | 6,573 | 5,125 | 4,429 | 1,391 | 2,556 | 1,152 |
| Inventory | N/A | 684 | 1,906 | 1,723 | 2,464 | 1,786 | 3,236 |
| Trade Receivables | 1,208 | 6,612 | 4,045 | 7,440 | 4,582 | 10,465 | 10,626 |
| Trade Payables | 622 | 762 | 2,657 | 1,769 | 1,388 | 2,220 | 1,152 |
| Net Working Capital | 4,142 | 1,683 | 1,738 | 5,661 | 7,327 | 11,798 | 14,418 |
| Net Working Capital % of Revenue | 17.6% | 4.5% | 3.5% | 7.9% | 7.9% | 10.6% | 12.1% |
| Trade Working Capital | 586 | 6,534 | 3,294 | 7,394 | 5,658 | 10,030 | 12,710 |
| Trade Working Capital % of Revenue | 2.5% | 17.6% | 6.7% | 10.4% | 6.1% | 9.0% | 10.6% |
| Change in Trade Working Capital | N/A | 5,948 | -3,240 | 4,101 | -1,736 | 4,372 | 2,680 |
| Turnover & efficiency | |||||||
| Inventory Turnover | N/A | 48.30x | 23.69x | 35.63x | 34.37x | 54.01x | 33.59x |
| Days Inventory Outstanding (DIO) | N/A | 7.6 | 15.4 | 10.2 | 10.6 | 6.8 | 10.9 |
| Receivables Turnover | 19.45x | 5.60x | 12.15x | 9.57x | 20.24x | 10.60x | 11.25x |
| Days Sales Outstanding (DSO) | 18.8 | 65.1 | 30.0 | 38.1 | 18.0 | 34.4 | 32.4 |
| Payables Turnover | 31.95x | 43.32x | 16.99x | 34.71x | 61.01x | 43.44x | 94.33x |
| Days Payable Outstanding (DPO) | 11.4 | 8.4 | 21.5 | 10.5 | 6.0 | 8.4 | 3.9 |
| Cash Conversion Cycle | 7.3 days | 64.3 days | 24.0 days | 37.9 days | 22.7 days | 32.8 days | 39.4 days |
| Asset Turnover | 4.28x | 4.05x | 6.72x | 6.72x | 9.93x | 7.22x | 7.14x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | 62 | -239 | 3,907 | 978 | 5,212 | 2,485 | 658 |
| Free Cash Flow (OCF − Capex proxy) | 62 | -239 | 3,778 | 735 | 4,933 | 1,625 | 133 |
| Cash Conversion (OCF / EBITDA) | 3.5% | -12.4% | 529.5% | 22.7% | 186.9% | 38.8% | 19.7% |
| Dividends Declared | N/A | 0 | 0 | 301 | 1,075 | 1,127 | 800 |
| Dividend Payout Ratio | N/A | 0.0% | N/A | 7.0% | 37.7% | 18.8% | 24.5% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).